grant
Cancer Mechanisms
Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAILocation NEW YORK, UNITED STATESPosted 1 Aug 2015Deadline 31 Jul 2030
NIHUS FederalResearch GrantFY2025AccelerationAreaAwardBasic ResearchBasic ScienceBiochemicalBiologic ModelsBiological MarkersBiological ModelsBiologyBreast CancerCCSGCancer BiologyCancer Center Support GrantCancer ControlCancer Control ScienceCancersCatchment AreaCell BodyCell Communication and SignalingCell SignalingCell-Extracellular MatrixCellsCellular biologyClinicalClinical PathsClinical PathwaysClinical TrialsCollaborationsCommunitiesDedicationsDetectable Residual DiseaseDevelopmentDiagnosisDirect CostsDiseaseDisorderECMEducationEducation and TrainingEducational aspectsElementsEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessExtracellular MatrixFacultyFibroblastsFocus GroupsFosteringFundingGene Action RegulationGene Expression RegulationGene RegulationGene Regulation ProcessGenesGeneticGoalsGrantHematopoietic Cell TumorHematopoietic MalignanciesHematopoietic NeoplasmsHematopoietic Neoplasms including LymphomasHematopoietic TumorHematopoietic and Lymphoid Cell NeoplasmHematopoietic and Lymphoid NeoplasmsHepatic CancerHospitalsImmuneImmunesInternationalIntracellular Communication and SignalingInvestigatorsJournalsKnowledgeLiquid substanceMagazineMaintenanceMalignant Breast NeoplasmMalignant Hematopoietic NeoplasmMalignant NeoplasmsMalignant TumorMalignant Tumor of the LungMalignant neoplasm of liverMalignant neoplasm of lungMalignant neoplasm of prostateMalignant prostatic tumorMetabolicMetastasisMetastasizeMetastatic LesionMetastatic MassMetastatic NeoplasmMetastatic TumorMinimal Residual DiseaseModel SystemModelingMolecularNCI-Designated Cancer CenterNatureNeoplasm MetastasisOrganoidsOutcomeOutputPaperPathway interactionsPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPeer ReviewPhasePopulationPreventionPrimary Cancer PreventionProgenitor CellsProstate CAProstate CancerProstate malignancyPublicationsPublishingPulmonary CancerPulmonary malignant NeoplasmRecurrenceRecurrentRecurrent Malignant NeoplasmRecurrent Malignant TumorResearchResearch PersonnelResearchersResidual NeoplasmResidual TumorsResistanceScienceScientific PublicationSecondary NeoplasmSecondary TumorSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSolid NeoplasmSolid TumorStrategic PlanningTechnologyTherapeutic InterventionTrainingTraining and EducationTranscriptional ControlTranscriptional RegulationTranslatingTranslational ResearchTranslational ScienceTranslationsTumor BiologyUniversitiesWorkbio-markersbiologic markerbiological signal transductionbiomarkerbiomarker identificationblood cancercancer diagnosiscancer immunologycancer initiationcancer metastasiscancer microenvironmentcancer of bloodcancer of the bloodcancer preventioncancer progressioncancer recurrencecancer typecell biologyclinical investigationclinical translationclinically translatablecollaborative approachdevelopmentalempowermentepigenetic regulationepigeneticallyfluididentification of biomarkersidentification of new biomarkersimprovedindustrial partnershipindustry partnerindustry partnershipinsightintervention therapyliquidliver cancerliver malignancylung cancermalignancymalignant breast tumormalignant liver tumormarker identificationmedical collegemedical schoolsmeetingmeetingsmembermouse modelmurine modelneoplasm immunologyneoplasm progressionneoplasm/cancerneoplastic progressionnew drug targetnew druggable targetnew markernew pharmacotherapy targetnew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapeutic targetnew therapy approachesnew therapy targetnew treatment approachnew treatment strategynovel biomarkernovel drug targetnovel druggable targetnovel markernovel pharmacotherapy targetnovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapeutic targetnovel therapy approachnovel therapy targetpathwaypatient oriented outcomesprogramsresidual diseaseresistantresponse to therapyresponse to treatmentschool of medicinestem cellssuccesstargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapeutic responsetherapy responsetraining opportunitytranslationtranslation researchtranslational impacttranslational investigationtranslational medicinetreatment responsetreatment responsivenesstumor cell metastasistumor immunologytumor microenvironmenttumor progressionwork groupworking group
Description preview
The Cancer Mechanisms (CM) Program of The Tisch Cancer Institute (TCI) is comprised of 57 members who share a common goal to catalyze basic research pertinent to cancer-relevant mechanistic discovery with the ultimate goal of generating new knowledge leading to enhanced diagnosis, treatment, and prevention of primary cancer and systemic recurrence…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click